Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-15

Clinical Trial Update: Vaporized Cannabis and Spinal Cord Injury Pain [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating vaporized cannabis for spinal cord injury–related pain has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vaporized Cannabis (Cannabis)

Snippet

Sponsor: Barth Wilsey | Conditions: Spinal Cord Injuries, Spinal Cord Diseases | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-01-15